JP2020529208A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529208A5 JP2020529208A5 JP2020505253A JP2020505253A JP2020529208A5 JP 2020529208 A5 JP2020529208 A5 JP 2020529208A5 JP 2020505253 A JP2020505253 A JP 2020505253A JP 2020505253 A JP2020505253 A JP 2020505253A JP 2020529208 A5 JP2020529208 A5 JP 2020529208A5
- Authority
- JP
- Japan
- Prior art keywords
- mrna
- utr
- skin
- fgf
- systems
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023115343A JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17183990.5A EP3437650A1 (en) | 2017-07-31 | 2017-07-31 | Treatment of local skin hypotrophy conditions |
| EP17183990.5 | 2017-07-31 | ||
| PCT/EP2018/070712 WO2019025431A1 (en) | 2017-07-31 | 2018-07-31 | TREATMENT OF LOCAL SKIN HYPOTROPHIC CONDITIONS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115343A Division JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529208A JP2020529208A (ja) | 2020-10-08 |
| JP2020529208A5 true JP2020529208A5 (https=) | 2021-09-09 |
Family
ID=59506101
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505253A Pending JP2020529208A (ja) | 2017-07-31 | 2018-07-31 | 局所皮膚低栄養状態の治療 |
| JP2023115343A Withdrawn JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115343A Withdrawn JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200369738A1 (https=) |
| EP (2) | EP3437650A1 (https=) |
| JP (2) | JP2020529208A (https=) |
| KR (1) | KR20200035073A (https=) |
| CN (1) | CN111050785A (https=) |
| AU (1) | AU2018311128A1 (https=) |
| CA (1) | CA3070880A1 (https=) |
| WO (1) | WO2019025431A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022012683A (es) * | 2020-04-09 | 2023-01-11 | Verve Therapeutics Inc | Edicion de bases de pcsk9 y metodos de uso de la misma para el tratamiento de enfermedades. |
| US20220015986A1 (en) * | 2020-07-16 | 2022-01-20 | Hillary Hayman | Three-step process for mimicking plastic surgery results |
| CN114717230B (zh) * | 2021-01-05 | 2024-09-03 | 麦塞拿治疗(香港)有限公司 | 成纤维细胞生长因子mRNA的无细胞和无载体体外RNA转录方法和核酸分子 |
| WO2023012722A1 (en) * | 2021-08-06 | 2023-02-09 | Leadermed Champion Limited | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF |
| KR102432810B1 (ko) * | 2021-10-29 | 2022-08-16 | 주식회사 엣지케어 | 약물전달 시스템 및 약물전달 시스템의 동작방법 |
| WO2024151673A2 (en) * | 2023-01-09 | 2024-07-18 | President And Fellows Of Harvard College | Recombinant nucleic acid molecules and their use in wound healing |
| CN120137909A (zh) * | 2025-03-12 | 2025-06-13 | 广州酷奇圈科研与推广应用有限公司 | 重组外泌体及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1168997B1 (en) | 1999-04-02 | 2013-04-24 | KCI Licensing, Inc. | Vacuum assisted closure system with provision for introduction of agent |
| US7202226B2 (en) * | 2000-10-23 | 2007-04-10 | Detroit R & D | Augmentation of wound healing by elF-4E mRNA and EGF mRNA |
| KR20060123256A (ko) * | 2003-11-11 | 2006-12-01 | 가부시키가이샤 시세이도 | 모발의 태모화 방법 및 조성물 |
| US7816140B2 (en) | 2005-06-14 | 2010-10-19 | The United States Of America As Represented By The Department Of Veterans Affairs | Composition and methods for osteogenic gene therapy |
| RU2008128451A (ru) * | 2005-12-14 | 2010-01-20 | Огенодженесис, Инк. (US) | Композиция для лечения и ухода за кожей, способ ее получения, способ ее использования |
| US20100143289A1 (en) | 2006-12-19 | 2010-06-10 | Michael Cohen | Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof |
| WO2009030464A2 (de) | 2007-09-08 | 2009-03-12 | Bayer Schering Pharma Aktiengesellschaft | HERSTELLUNG UND VERWENDUNG VON VARIANTEN HUMANER KUNITZ-TYP PROTEASE-INHIBITOREN (hKTPI) |
| WO2009119073A1 (ja) * | 2008-03-28 | 2009-10-01 | 北海道公立大学法人札幌医科大学 | 皮膚の老化や瘢痕の治療剤 |
| WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| PT2670411T (pt) | 2011-02-02 | 2019-06-18 | Excaliard Pharmaceuticals Inc | Compostos anti sentido visando um fator de crescimento do tecido conetivo (ctfg) para utilização num método de tratamento de queloides ou cicatrizes hipertróficas |
| US8759287B2 (en) | 2011-04-12 | 2014-06-24 | M-3 Biologics, Llc | Methods of decreasing incisional hernia formation and acute wound failure in obese patients by administering basic fibroblast growth factor |
| WO2013002331A1 (ja) * | 2011-06-28 | 2013-01-03 | 株式会社バイオセレンタック | 皮膚治療用微細針集積型製剤 |
| US9439940B2 (en) | 2011-07-19 | 2016-09-13 | Neville Pharmaceutical, Inc. | Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation |
| WO2013120497A1 (en) * | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
| EP4331620A3 (en) | 2012-12-07 | 2024-12-04 | Translate Bio, Inc. | Lipidic nanoparticles for mrna delivery |
| RS57739B1 (sr) | 2013-03-14 | 2018-12-31 | Translate Bio Inc | Kompozicije cftr irnk i postupci i upotrebe u vezi sa njima |
| EP3099801B1 (en) * | 2014-01-31 | 2020-03-18 | Factor Bioscience Inc. | Synthetic rna for use in the treatment of dystrophic epidermolysis bullosa |
| WO2016100820A2 (en) | 2014-12-19 | 2016-06-23 | Salk Institute For Biological Studies | Fgf2 truncations and mutants and uses thereof |
| CA2976376A1 (en) | 2015-02-13 | 2016-08-18 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
-
2017
- 2017-07-31 EP EP17183990.5A patent/EP3437650A1/en not_active Withdrawn
-
2018
- 2018-07-31 CA CA3070880A patent/CA3070880A1/en active Pending
- 2018-07-31 AU AU2018311128A patent/AU2018311128A1/en not_active Abandoned
- 2018-07-31 CN CN201880056980.3A patent/CN111050785A/zh active Pending
- 2018-07-31 JP JP2020505253A patent/JP2020529208A/ja active Pending
- 2018-07-31 EP EP18746712.1A patent/EP3661540A1/en active Pending
- 2018-07-31 WO PCT/EP2018/070712 patent/WO2019025431A1/en not_active Ceased
- 2018-07-31 KR KR1020207005199A patent/KR20200035073A/ko not_active Withdrawn
- 2018-07-31 US US16/635,857 patent/US20200369738A1/en not_active Abandoned
-
2023
- 2023-07-13 JP JP2023115343A patent/JP2023145532A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020529208A5 (https=) | ||
| JP2020515644A5 (https=) | ||
| Escobar‐Chávez et al. | Electroporation as an efficient physical enhancer for skin drug delivery | |
| JP2023075165A (ja) | 核酸生成及び送達のための方法及び製品 | |
| US20170087224A1 (en) | Delivery methods and compositions | |
| JP2018506542A5 (https=) | ||
| EP3275459A2 (en) | Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition | |
| CN109381422B (zh) | 一种经皮吸收组合物及其在制备经皮吸收制剂中的用途 | |
| KR102760486B1 (ko) | 다중-인자 모발 성장 제제 | |
| JP2020529208A (ja) | 局所皮膚低栄養状態の治療 | |
| Bhavsar et al. | Strategies for transportation of peptides across the skin for treatment of multiple diseases | |
| Bhat et al. | Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics? | |
| CN112245571A (zh) | 一种用于乌发的脂质体制剂及其制备方法 | |
| CN106084006B (zh) | 一种透皮肽及其应用 | |
| KR20190123256A (ko) | 액취증 치료 방법 | |
| Ma et al. | Dendritic lipopeptide-based transdermal siRNA delivery systems for effective non-invasive therapy in psoriasis | |
| CN117050164A (zh) | 透皮增强肽及其应用 | |
| WO2005039642B1 (en) | Dna delivery with gemini cationic surfactants | |
| RU2012146542A (ru) | Способ ингибирования репликации вич в клетках млекопитающих и у людей | |
| EP1671655A1 (en) | Gene therapy for skin diseases using needle free syringe | |
| WO2018023148A1 (en) | Skin care formulation | |
| Chen et al. | Research progress on the application of microneedle transdermal drug delivery system in dermatology | |
| Li et al. | Elastin-like peptides for efficient and safe delivery of mRNA | |
| CN109602911B (zh) | 硫酸钙晶须或其组合物在制备皮肤促渗剂中的用途 | |
| Singh et al. | Peptide-mediated transdermal drug delivery |